ABBVIE, INC. for ABBVIE INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2013 | $1,180,000 | Replaced |
| 3rd Quarter - Amendment | Jan 21, 2014 | $1,220,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 214 Preserve Access to Affordable Generics Act of 2013; Numerous bills/drafts on Patent Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
Trade (domestic/foreign) TRD
Variety of international trade issues (CAFTA, TPA, TPP, KFTA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| ANDREW KAPLAN | — |
Taxation/Internal Revenue Code TAX
Proposals to reform domestic and international tax structures
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| HEATHER STRAWN | — |
| ADELE R WITENSTEIN | — |
Health Issues HCR
Public law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA; Proposals to improve viral hepatitis screening and testing; S. 621 & H.R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Implementation of the Prescription Drug User Fee Act (PDUFA); H.R. 3204, Drug Quality & Security Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| ADELE R WITENSTEIN | — |
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicare; Medicare payment proposals, S. 117/H.R. 1102 Medicare Prescription Drug Price Negotiation Act of 2013; S. 740/H.R. 1558 Medicare Drug Savings Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| ADELE R WITENSTEIN | — |
Budget/Appropriations BUD
H.R. 2725, Food & Drug Administration Safety Over Sequestration Act of 2013; S. 1413, FDA User Fee Protection Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.